BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19188497)

  • 21. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells.
    Schildknecht A; Brauer S; Brenner C; Lahl K; Schild H; Sparwasser T; Probst HC; van den Broek M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):199-203. PubMed ID: 20018763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
    Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
    J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.
    Tivol EA; Gorski J
    J Immunol; 2002 Aug; 169(4):1852-8. PubMed ID: 12165509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
    Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of molecules associated with T-regulatory function by thymoglobulin pretreatment of human CD4+ cells.
    Liu Z; Fang Y; Wang X; Wang P; Yun P; Xu H
    Transplantation; 2008 Nov; 86(10):1419-26. PubMed ID: 19034013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage.
    Jin LP; Chen QY; Zhang T; Guo PF; Li DJ
    Clin Immunol; 2009 Dec; 133(3):402-10. PubMed ID: 19766059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis.
    Watanabe K; Rao VP; Poutahidis T; Rickman BH; Ohtani M; Xu S; Rogers AB; Ge Z; Horwitz BH; Fujioka T; Erdman SE; Fox JG
    Infect Immun; 2008 Dec; 76(12):5834-42. PubMed ID: 18824539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.
    Homann D; Dummer W; Wolfe T; Rodrigo E; Theofilopoulos AN; Oldstone MB; von Herrath MG
    J Virol; 2006 Jan; 80(1):270-80. PubMed ID: 16352552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses.
    Chambers CA; Kuhns MS; Allison JP
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8603-8. PubMed ID: 10411922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTLA-4 expressed by FOXP3
    Klocke K; Holmdahl R; Wing K
    Immunology; 2017 Sep; 152(1):125-137. PubMed ID: 28497863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
    De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
    Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of different cyto-stimuli on immunological activity of splenic regulatory T cells in mice].
    Zhang Y; Yao YM; Chang Q; Dong N
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):142-5. PubMed ID: 17376265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge.
    Rowe JH; Johanns TM; Ertelt JM; Lai JC; Way SS
    Immunology; 2009 Sep; 128(1 Suppl):e471-8. PubMed ID: 19191906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
    Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
    Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient attenuated Foxp3 expression on CD4⁺ T cells treated with 7D4 mAb contributes to the control of parasite burden in DBA / 2 mice infected with lethal Plasmodium chabaudi chabaudi AS.
    Feng H; Zhu XT; Qi ZM; Wang QH; Wang GG; Pan YY; Li Y; Zheng L; Jiang YJ; Shang H; Cui L; Cao YM
    Scand J Immunol; 2012 Jan; 75(1):46-53. PubMed ID: 21916916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.
    Wing K; Yamaguchi T; Sakaguchi S
    Trends Immunol; 2011 Sep; 32(9):428-33. PubMed ID: 21723783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting edge: CD47 controls the in vivo proliferation and homeostasis of peripheral CD4+ CD25+ Foxp3+ regulatory T cells that express CD103.
    Van VQ; Darwiche J; Raymond M; Lesage S; Bouguermouh S; Rubio M; Sarfati M
    J Immunol; 2008 Oct; 181(8):5204-8. PubMed ID: 18832672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.
    Sather BD; Treuting P; Perdue N; Miazgowicz M; Fontenot JD; Rudensky AY; Campbell DJ
    J Exp Med; 2007 Jun; 204(6):1335-47. PubMed ID: 17548521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.